In vitro assays suggest this may reduce the oncogenic stress of high-level expression of DUX4. Patient samples of IGH-DUX4 B-ALL have similar expression profiles and IGH breakpoints as Nalm6, suggesting this could be a common mechanism; further analyses of haplotype structure and epigenetic profiling are required. The gene discussed is DUX4; the disease is acute lymphoblastic leukemia.